A novel human STAT3 mutation presents with autoimmunity involving Th17 hyperactivation

Area of Science:

• Immunology
• Genetics
• Molecular Biology

Background:

• Signal transducer and activator of transcription 3 (STAT3) mutations are linked to autoimmune diseases via lymphoproliferation.
• The Th17 pathway plays a critical role in immune responses and is implicated in autoimmune pathogenesis.

Observation:

• A novel Pro471Arg STAT3 mutation was identified in a patient with multiple autoimmune diseases.
• This mutation led to hyperactivation of the Th17 pathway, evidenced by enhanced IL-17 production from primary T cells.
• IL-17 production was not further boosted by IL-6 but was reduced by IL-10, and STAT3 inhibition decreased IL-17 levels.

Findings:

• The Pro471Arg STAT3 mutation resulted in elevated IgA and IgG levels, potentially due to increased IL-21.
• Therapeutic intervention led to normalized IL-17 levels and clinical remission.
• These findings support the hypothesis that STAT3 gain-of-function mutations drive autoimmunity through Th17 pathway hyperactivation.

Implications:

• STAT3 gain-of-function mutations are a direct cause of autoimmune conditions by dysregulating the Th17 pathway.
• Targeting STAT3 activation or the Th17 pathway may offer therapeutic strategies for autoimmune diseases.
• Understanding the molecular mechanisms of STAT3 mutations provides insights into immune system dysregulation in autoimmunity.